Men with coronary artery disease who used phosphodiesterase-5 (PDE-5) inhibitors for erectile dysfunction had fewer adverse cardiovascular events than those taking the prostaglandin drug alprostadil ...

Men with stable CAD who are being treated for erectile dysfunction (ED) have a lower risk of dying if their medication is a phosphodiesterase 5 (PDE5) inhibitor rather than alprostadil, observational ...

Men who filled prescriptions for erectile dysfunction drugs in the years following a heart attack had a substantially lower risk of dying or being hospitalized for heart failure than men who did not ...

Taxpayers paid more than $3.1 million in 2007 and 2008 for sexual or erectile dysfunction drugs such as Viagra that should not have been reimbursed under federal rules for Part D, according to a ...

Although ED is common, you don’t have to live with it. Our urological specialists understand your hesitation and frustration. We offer a range of personalized treatments to help you achieve the sexual ...

Erectile dysfunction or impotency affects 18 to 20 million men every year in the United States. However, there has been a great change in treatment since 1998 when the first successful oral form of ...

Diabetes mellitus (DM) is strongly associated with an increased risk of erectile dysfunction (ED), the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual ...

Erectile dysfunction (ED) is an inability to achieve or maintain an erection during sex or with sexual stimulation. It can affect people at any age but becomes more common as you age. ED affects about ...